Form 4: West Pharmaceutical Services Insider Trading Activity
Statement of Changes in Beneficial Ownership
Annette Favorite, Sr. VP & Chief HR Officer at West Pharmaceutical Services, reported transactions involving common stock and stock options.
Summary
- Annette Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services Inc., engaged in transactions on April 27, 2026.
- She acquired 2,817 shares of common stock at a weighted average price of $83.47 per share.
- She also disposed of 2,817 shares of common stock at a price of $305.20 per share.
- Following these transactions, Favorite beneficially owns 16,828.4906 shares of common stock directly and 4,966.617 shares indirectly through a Non-Qualified Deferred Compensation Plan.
- Additionally, she exercised stock options to acquire 2,817 shares of common stock at an exercise price of $83.47 per share, with the options granted on February 21, 2017, and vesting annually starting February 21, 2018, expiring on February 21, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions rather than company performance or strategic shifts. The profitable exercise and sale of options is typical for executives.
Positives
- The exercise of stock options at a price significantly lower than the disposal price ($83.47 vs $305.20) indicates a profitable transaction for the reporting person.
- The acquisition of shares at $83.47 suggests a potential reinvestment or belief in the company's value at that price point, although this is offset by the sale at a much higher price.
Negatives
- The disposal of 2,817 shares at $305.20 per share represents a significant sale of common stock by a key executive.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The significant difference between the exercise price of options and the sale price of common stock for Annette Favorite at West Pharmaceutical Services Inc. (WST) suggests a profitable outcome for the executive, which is common when stock options are exercised and sold in a rising market.
Stakeholder Impact
- Shareholders may observe insider selling as a signal, though the context of option exercise and sale at a profit is a common executive compensation event.
Key Dates
| Date | Description |
|---|---|
| 02/21/2017 | Date stock options were granted. |
| 02/21/2018 | First annual installment of stock option vesting began. |
| 04/27/2026 | Date of reported transactions (acquisition and disposal of common stock, exercise of stock options). |
| 04/29/2026 | Date of signature on the filing. |
| 02/21/2027 | Expiration date of stock options. |
Keywords
Form 4, Insider Trading, West Pharmaceutical Services, WST, Stock Options, Beneficial Ownership, Executive Transactions, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.